Drug recall · October 2, 2019
Quinacrine Dihydrochloride recall
Why: Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707
- Lots / codes
Lot#: a) DL4654A, Exp. 04/27/21; b) DR4654, Exp. 04/27/21 c) DR4654, Exp. 04/27/21
- Quantity
- 1.8 kilograms
- Company
- Darmerica, LLC, Casselberry, FL
- Distribution
- U.S.A. Nationwide
- Initiated
- September 6, 2019 · Voluntary: Firm initiated
- Classified
- October 3, 2019
- Reported
- October 2, 2019
- Ended
- February 5, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.